<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Dermatology: Drug Prescribing Behavior Topic Collection</title>
    <link>http://archderm.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 17 Apr 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Wed, 17 Apr 2013 16:10:17 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archderm.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archderm.jamanetwork.com</webMaster>
    <item>
      <title>Trends and Antibiotic Susceptibility Patterns of Methicillin-Resistant and Methicillin-Sensitive  Staphylococcus aureus  in an Outpatient Dermatology Facility Methicillin-Resistant and -Sensitive  S aureus  </title>
      <link>http://archderm.jamanetwork.com/article.aspx?articleID=1557490</link>
      <pubDate>Mon, 01 Apr 2013 00:00:00 GMT</pubDate>
      <author>Zabielinski M,  McLeod MP, Aber C, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Objectives&lt;/div&gt;To determine whether the relative proportions of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S aureus (MSSA) were changing or stable in an outpatient dermatology clinic and to examine the antibiotic susceptibility profiles of S aureus isolates.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Retrospective observational data were collected from skin culture isolates annually between January 1, 2005, and December 31, 2010, and monthly during the 6-month period of January 1, 2011, to June 30, 2011.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;The University of Miami Hospital outpatient dermatology clinic.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;A total of 387 S aureus isolates were analyzed between January 1, 2005, and June 30, 2011, from adult and pediatric patients.&lt;div class="boxTitle"&gt;Main Outcome Measures&lt;/div&gt;The relative proportions of MRSA and MSSA skin culture isolates were measured, along with antibiotic sensitivity profiles.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;The overall relative proportion of MRSA was 35.7%. The overall relative proportion of MSSA was 64.3%. During the last 6 months of the study, the relative proportion of MRSA was 33.3%, while the relative proportion of MSSA was 66.7%. The relative proportion of MRSA from January 1, 2008, through December 31, 2010, was significantly higher than the relative proportion from January 1, 2005, through December 31, 2007 (45.3% vs 28.3%, P = .001). MRSA became more sensitive to ciprofloxacin, while MSSA became more resistant to ciprofloxacin, clindamycin, gentamicin sulfate, and trimethoprim-sulfamethoxazole.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;The relative proportion of MRSA in the S aureus isolates increased by 17.0% during the last 3 years of our study. Despite this increase, MRSA became more sensitive to ciprofloxacin, while MSSA demonstrated increased antibiotic resistance to ciprofloxacin, clindamycin, gentamicin, and trimethoprim-sulfamethoxazole.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">149</prism:volume>
      <prism:number xmlns:prism="prism">4</prism:number>
      <prism:startingPage xmlns:prism="prism">427</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">432</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamadermatol.2013.2424</prism:doi>
      <guid>http://archderm.jamanetwork.com/article.aspx?articleID=1557490</guid>
    </item>
  </channel>
</rss>